Compare with Unichem Lab - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALKEM LABORATORIES vs UNICHEM LAB - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALKEM LABORATORIES UNICHEM LAB ALKEM LABORATORIES/
UNICHEM LAB
 
P/E (TTM) x - -102.4 - View Chart
P/BV x 6.7 0.6 1,193.0% View Chart
Dividend Yield % 0.6 2.5 26.2%  

Financials

 ALKEM LABORATORIES   UNICHEM LAB
EQUITY SHARE DATA
    ALKEM LABORATORIES
Mar-16
UNICHEM LAB
Mar-19
ALKEM LABORATORIES/
UNICHEM LAB
5-Yr Chart
Click to enlarge
High Rs1,589292 544.2%   
Low Rs1,232182 676.9%   
Sales per share (Unadj.) Rs417.5167.7 249.0%  
Earnings per share (Unadj.) Rs56.3-3.6 -1,550.5%  
Cash flow per share (Unadj.) Rs64.75.9 1,089.0%  
Dividends per share (Unadj.) Rs12.704.00 317.5%  
Dividend yield (eoy) %0.91.7 53.3%  
Book value per share (Unadj.) Rs292.9372.3 78.7%  
Shares outstanding (eoy) m119.5770.38 169.9%   
Bonus/Rights/Conversions -ESOP-  
Price / Sales ratio x3.41.4 239.0%   
Avg P/E ratio x25.1-65.3 -38.4%  
P/CF ratio (eoy) x21.839.9 54.6%  
Price / Book Value ratio x4.80.6 756.3%  
Dividend payout %22.6-110.2 -20.5%   
Avg Mkt Cap Rs m168,65316,680 1,011.1%   
No. of employees `000NA2.6 0.0%   
Total wages/salary Rs m9,1712,393 383.2%   
Avg. sales/employee Rs ThNM4,535.2-  
Avg. wages/employee Rs ThNM919.8-  
Avg. net profit/employee Rs ThNM-98.2-  
INCOME DATA
Net Sales Rs m49,91511,801 423.0%  
Other income Rs m1,645984 167.2%   
Total revenues Rs m51,56112,785 403.3%   
Gross profit Rs m8,482-835 -1,016.0%  
Depreciation Rs m1,006674 149.3%   
Interest Rs m67175 891.8%   
Profit before tax Rs m8,451-600 -1,409.2%   
Minority Interest Rs m-1140-   
Prior Period Items Rs m01 0.0%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,606-343 -467.6%   
Profit after tax Rs m6,731-256 -2,634.2%  
Gross profit margin %17.0-7.1 -240.2%  
Effective tax rate %19.057.3 33.2%   
Net profit margin %13.5-2.2 -622.8%  
BALANCE SHEET DATA
Current assets Rs m27,06220,384 132.8%   
Current liabilities Rs m15,3245,029 304.7%   
Net working cap to sales %23.5130.1 18.1%  
Current ratio x1.84.1 43.6%  
Inventory Days Days67105 63.5%  
Debtors Days Days41135 30.6%  
Net fixed assets Rs m12,6109,023 139.7%   
Share capital Rs m239141 169.8%   
"Free" reserves Rs m34,49026,058 132.4%   
Net worth Rs m35,02726,199 133.7%   
Long term debt Rs m1,2120-   
Total assets Rs m54,38731,496 172.7%  
Interest coverage x13.6-7.0 -195.0%   
Debt to equity ratio x00-  
Sales to assets ratio x0.90.4 245.0%   
Return on assets %13.6-0.6 -2,377.0%  
Return on equity %19.2-1.0 -1,970.3%  
Return on capital %24.9-2.0 -1,243.3%  
Exports to sales %12.969.4 18.7%   
Imports to sales %3.10-   
Exports (fob) Rs m6,4618,188 78.9%   
Imports (cif) Rs m1,540NA-   
Fx inflow Rs m6,5638,188 80.2%   
Fx outflow Rs m3,012596 505.3%   
Net fx Rs m3,5527,592 46.8%   
CASH FLOW
From Operations Rs m7,259-3,278 -221.5%  
From Investments Rs m1,864-2,860 -65.2%  
From Financial Activity Rs m-9,273-24 38,316.9%  
Net Cashflow Rs m-150-4,690 3.2%  

Share Holding

Indian Promoters % 66.9 50.1 133.5%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 33.1 15.1 219.2%  
FIIs % 0.0 3.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 0.0 31.7 -  
Shareholders   68,381 20,176 338.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALKEM LABORATORIES With:   JUBILANT LIFE SCIENCES  PANACEA BIOTECH  CADILA HEALTHCARE  GSK PHARMA  PLETHICO PHARMA  

Compare ALKEM LABORATORIES With:   MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 21 Points Higher; Banking and Oil & Gas Stocks Witness Buying(Closing)

Indian share markets witnessed buying interest during closing hours today and ended their day marginally higher.

Related Views on News

UNICHEM LAB Announces Quarterly Results (1QFY20); Net Profit Up 102.2% (Quarterly Result Update)

Jul 30, 2019 | Updated on Jul 30, 2019

For the quarter ended June 2019, UNICHEM LAB has posted a net profit of Rs 5 m (up 102.2% YoY). Sales on the other hand came in at Rs 2 bn (up 15.4% YoY). Read on for a complete analysis of UNICHEM LAB's quarterly results.

UNICHEM LAB 2018-19 Annual Report Analysis (Annual Result Update)

Jul 4, 2019 | Updated on Jul 4, 2019

Here's an analysis of the annual report of UNICHEM LAB for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of UNICHEM LAB. Also includes updates on the valuation of UNICHEM LAB.

UNICHEM LAB Announces Quarterly Results (4QFY19); Net Profit Up 31.7% (Quarterly Result Update)

May 29, 2019 | Updated on May 29, 2019

For the quarter ended March 2019, UNICHEM LAB has posted a net profit of Rs 37 m (up 31.7% YoY). Sales on the other hand came in at Rs 3 bn (up 35.1% YoY). Read on for a complete analysis of UNICHEM LAB's quarterly results.

UNICHEM LAB Announces Quarterly Results (3QFY19); Net Profit Up 110.9% (Quarterly Result Update)

Feb 4, 2019 | Updated on Feb 4, 2019

For the quarter ended December 2018, UNICHEM LAB has posted a net profit of Rs 63 m (up 110.9% YoY). Sales on the other hand came in at Rs 2 bn (up 53.8% YoY). Read on for a complete analysis of UNICHEM LAB's quarterly results.

UNICHEM LAB Announces Quarterly Results (2QFY19); Net Profit Down 61.4% (Quarterly Result Update)

Nov 5, 2018 | Updated on Nov 5, 2018

For the quarter ended September 2018, UNICHEM LAB has posted a net profit of Rs 177 m (down 61.4% YoY). Sales on the other hand came in at Rs 2 bn (down 42.6% YoY). Read on for a complete analysis of UNICHEM LAB's quarterly results.

More Views on News

Most Popular

7 Stocks That Will Generate Alpha over the Next Decade(Profit Hunter)

Oct 29, 2019

Here's your chance benefit from a safe approach to making money in stock markets .

Is Hawkins Set to Become Our Next Superhero Stock?(The 5 Minute Wrapup)

Nov 1, 2019

After PI Industries, Hawkins has put up a stellar show so far.

Ditch the Risky Fixed Deposits for Safer 'Bluechip Deposits'(Profit Hunter)

Oct 30, 2019

Most people think stocks are riskier than fixed deposits and bonds. The last quarter century proves otherwise.

What to Buy at Sensex 40,000(The 5 Minute Wrapup)

Nov 4, 2019

Should you invest in high-quality, safe stocks or make some contrarian bets in the smallcap space?

The Top Stocks for 2020 Pass This Most Critical Metric(The 5 Minute Wrapup)

Nov 5, 2019

Charlie Munger's favorite fictional character, Mr Glotz, picks stocks using this metric.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

ALKEM LABORATORIES SHARE PRICE


Nov 11, 2019 (Close)

TRACK ALKEM LABORATORIES

  • Track your investment in ALKEM LABORATORIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ALKEM LABORATORIES

ALKEM LABORATORIES 5-YR ANALYSIS

COMPARE ALKEM LABORATORIES WITH

MARKET STATS